STAT News7d ago1 min read

STAT+: Replimune skin cancer drug that became FDA...

A cancer drug candidate that, rightly or wrongly, became a flashpoint at FDA, fails on a second try at approval.

Get the 10 best reads every Sunday

Curated by AI, voted by readers. Free forever.

Loading comments…

Hacker News10h ago

Healthchecks.io Now Uses Self-Hosted Object Storage

Discussed on Hacker News with 73 points and 41 comments.

STAT News19d ago

Lilly has signed a deal with AI drug developer Insilico that’s worth $115 million up front and approximately $2.75 billion in biobucks

STAT News18d ago

Whoever takes over the CDC next will face immediate and enormous challenges. Here are a few.

Liked this? Start your own feed.